ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

Last updated: November 12, 2024
Sponsor: Ferring Pharmaceuticals
Overall Status: Active - Recruiting

Phase

N/A

Condition

Bladder Cancer

Urothelial Carcinoma

Urothelial Cancer

Treatment

ADSTILADRIN

Clinical Study ID

NCT06026332
000431
  • Ages > 18
  • All Genders

Study Summary

Multi-center, prospective non-interventional study to collect data on the early use of Adstiladrin in the US and Israel. Data will be collected from patients and prescribing physicians in a real-world setting

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Prescribed and scheduled treatment with ADSTILADRIN per physician discretion orreceived the first instillation of ADSTILADRIN per physician discretion after 5September 2023 but prior to site activation

  • Signed and dated ICF.

  • Age 18 years or older at day ICF is signed.

Exclusion

Exclusion Criteria:

  • Currently enrolled in a clinical trial.

  • Participants who have previously been treated with ADSTILADRIN in the context of aclinical trial

  • Participant is pregnant or breastfeeding.

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: ADSTILADRIN
Phase:
Study Start date:
September 15, 2023
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Ferring Investigational Site

    Gilbert, Arizona 85234
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Little Rock, Arkansas 72211
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Fresno, California 93720
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Los Angeles, California 90033
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Gainesville, Florida 32608
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Atlanta, Georgia 30328
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Greenwood, Indiana 46143
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Jeffersonville, Indiana 47130
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Wichita, Kansas 67226
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Baltimore, Maryland 21287
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Rochester, Minnesota 55905
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Omaha, Nebraska 68114
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Bronx, New York 10467
    United States

    Active - Recruiting

  • Ferring Investigational Site

    New York, New York 10032
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Syracuse, New York 13210
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Gahanna, Ohio 43230
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Myrtle Beach, South Carolina 29572
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Nashville, Tennessee 37209
    United States

    Active - Recruiting

  • Ferring Investigation Site

    Dallas, Texas 75390
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Charlottesville, Virginia 22908
    United States

    Active - Recruiting

  • Ferring Investigational Site

    Virginia Beach, Virginia 23462
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.